Navigation Links
Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
Date:9/25/2013

C clinical trial," said Dr. Colin Hislop, Anthera's Chief Medical Officer. "The pathology of IgA nephropathy is heavily centered on the abundance of these proteins."

Oral Presentation: "Effects of Blisibimod, an Inhibitor of B Cell Activating Factor, on Serum Immunoglobulins and Infection Risk in Patients with Systemic Lupus Erythematosus: Observations from the Placebo-Controlled PEARL-SC and Open-Label Extension Studies": Clinical Aspects and Treatment: Biologic Therapy (2:30PM-4:00PM, October 28th)

Poster: "Effects of Chronic Treatment with Blisibimod, an Inhibitor of B Cell Activating Factor, on Renal and Inflammation Biomarkers in Patients with Systemic Lupus Erythematosus: Observations from the Placebo-Controlled PEARL-SC and Open-Label Extension Studies": Clinical Aspects Poster II: Central Nervous System Manifestation (8:30AM – 4:00PM, October 28th)

Anthera will be hosting a breakout session following the presentations by Dr. Furie. Please contact ir@anthera.com for the event details.

About Blisibimod and PEARL-SC

Anthera is developing blisibimod, a selective inhibitor of B-cell activating factor (BAFF), to explore its clinical utility in various autoimmune diseases including systemic lupus erythematosus (SLE) and IgA nephropathy. Blisibimod is a novel fusion protein, or peptibody, and is distinct from an antibody. Anthera owns worldwide rights to blisibimod in all potential indications. BAFF, also known as BLyS (B lymphocyte stimulator), is a tumor necrosis family member and is critical to the development, maintenance and survival of B-cells. B-cells represent a critical component of human immune response to infection and other pathogens.  However, abnormal elevations of B-cells and BAFF may lead to an overactive immune response which may damage normal healthy tissues and organ systems. Multiple clinical st
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
2. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
3. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
4. Anthera Pharmaceuticals Announces Personnel Changes
5. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
6. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
7. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
8. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
9. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
10. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
11. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... 2012, Fi Asia-China, Hi & Ni China ( ... beverage shows in China, will take place on ... International Expo Centre (SNIEC), organized by UBM Sinoexpo. ... http://www.prnasia.com/sa/2010/04/19/20100419602891.jpg ) As ...
...  For the first time in state of New York, PediaVision ... screener for approximately 125 of the children at Boys & ... Bronx, New York, on Thursday, March 22 beginning at 3 ... vision issues from the Spot screening are provided with the ...
Cached Medicine Technology:Fi Asia-China, Hi & Ni China is Ready for Return on June 2012 in Shanghai 2PediaVision to Conduct Free Screenings With "Spot" at Kips Bay Boys & Girls Club 2PediaVision to Conduct Free Screenings With "Spot" at Kips Bay Boys & Girls Club 3PediaVision to Conduct Free Screenings With "Spot" at Kips Bay Boys & Girls Club 4
(Date:7/9/2014)... Wakulich was told she had an aneurysm, she figured an ... , "I was devastated," said Wakulich, who is 56 years ... was a serious diagnosis. Then I met Dr. Bernard Bendok ... less invasive procedure. It was something I didn,t even know ... multi-center U.S. clinical trial to evaluate the safety and effectiveness ...
(Date:7/9/2014)... cancer, researchers have uncovered mutations in a cell-signaling pathway ... knowledge may expand treatments for patients because drugs targeting ... are in clinical trials. , Reporting July 9 in ... (TCGA), including researchers at Washington University School of Medicine ... studied tumors from 230 patients with lung adenocarcinoma. , ...
(Date:7/9/2014)... found that fecal transplantation is effective and safe for ... is the result of a study led by Colleen ... Gastrointestinal Medicine at The Women,s Medicine Collaborative. The study ... of print in the American Journal of Gastroenterology ... diff , has increased to epidemic proportions over the ...
(Date:7/9/2014)... N.Y. Although feelings are personal and subjective, ... code that objectively represents emotions across different senses, ... by Cornell University neuroscientist Adam Anderson. , "We ... the orbitofrontal cortex, an area of the brain ... code which captures an individual,s subjective feeling," says ...
(Date:7/9/2014)... NEW YORK (July 8, 2014) Researchers from ... College of Medicine of Yeshiva University will present ... being held July 12 July 17 in Copenhagen, ... triggers that could prompt transition from cognitive normality to ... of the Einstein Aging Study , established in ...
Breaking Medicine News(10 mins):Health News:New type of stent could help some brain aneurysm patients 2Health News:Lung cancer study hints at new treatments 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:Study cracks how the brain processes emotions 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3
... , , RADNOR, Pa., ... selected as the NIMH Outreach Partner for the state of ... in each state, Puerto Rico and the District of Columbia. ... over 80 National Partners, including professional, consumer, advocacy, and service-related ...
... ... keynote the upcoming Materials and Processes for Medical Devices Conference , Aug. 10-12 at ... (Vocus) ... keynote the upcoming Materials and Processes for Medical Devices Conference , Aug. 10-12 at ...
... , , BOSTON, July 27 ... today with community members and elected officials to celebrate the groundbreaking ... Massachusetts -- the $115 million Kroc Corps Community Center on the ... Chairman of the Kroc Campaign and a longtime supporter of the ...
... divorce and widowhood to poorer health , MONDAY, July 27 (HealthDay ... your health, but it has been less clear how you will ... Now, a new study shows that scenario spells trouble, even if ... who ceased being married at some point in their lives were ...
... N.Y., July 27, 2009By a wide margin, health care ... public and private health plans, and strongly support other ... payment reform and a national insurance health exchange with ... leaders feel it is urgent to enact comprehensive health ...
... , , WALTHAM, Mass., ... ADGE), a leading On-Site Utility offering clean electricity, heat, hot ... facilities, is pleased to announce that it has entered into ... of $3,492,650, which increases the equity of the Company,s common ...
Cached Medicine News:Health News:Feeling Blue Suicide Prevention Council Partners With the National Institute of Mental Health 2Health News:Minnesotans to Keynote Materials for Medical Devices Conference 2Health News:Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 2Health News:Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 3Health News:Marriage Ends, Health Declines 2Health News:Marriage Ends, Health Declines 3Health News:Health care leaders say need for reform is urgent 2Health News:American DG Energy Announces $3.5 Million Private Placement 2
Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Jaws with fine teeth. Serrated handle with polished finish. Jaws: Wide, 4.5 mm. With thumb catch lock....
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Medicine Products: